Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-17

FDA Approved: VIGABATRIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approves Amneal Pharmaceuticals NY LLC's supplemental application for Vigabatrin (ANDA210155). This action updates the approval for the generic product Viga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)